Kahira Pharmaceuticals & Chemical Industries Co. S.A.E (القاهرة للأدوية والصناعات الكيماوية)

See companies similar to Kahira Pharmaceuticals & Chemical Industries Co. S.A.E (القاهرة للأدوية والصناعات الكيماوية)»
« Back to previous page
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
4 Abd El-Hamed El-Deeb St.,Victoria Sguare, Shoubra,P.O Box 793
Cairo; Greater Cairo; Map
Tel: +20-2202,+20-2202
Fax: +20-2202
Email: @kahirapharma.com.eg

Full name: Kahira Pharmaceuticals & Chemical Industries Co. S.A.E

Status: Listed
Legal Form: Joint Stock Company
Operational Status: Operational
EMISid: 1437028
ISIN: EGS38391C016
Incorporation Date: 1991

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Human and veterinary drugs, cosmetics, chemical products

Company Description

Kahira Pharmaceuticals was established in 1962 through the merger of leading laboratories. Kahira Pharmaceuticals is headquartered in Cairo and it is engaged in production and distribution of human and veterinary pharmaceuticals products, such as analgesics, antipyretics, antirheumatics, vitamins, antibiotics, eye and nasal drops. The company is engaged in the production of cosmetics and other chemical products as well. Kahira Pharmaceuticals exports its production to the Gulf countries, Africa, Kazakhstan,…

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 19.75
Volume 4,020
Turnover 79,395
Index Healthcare and Pharmaceuticals
Market Egyptian Stock Exchange
Ticker CPCI.CA
Market Cap Market Cap 235,953
52 Week High 20.99
52 Week Low 14.35
Price to Earnings (P/E) 4.6
Earnings per Share (EPS) 4.3
Dividend Yield 1.65 (October 24, 2016)
Bookvalue 532,249
Enterprise Value 177,714
Quote updated on January 19, 2017
Note: data in EGP Thousands.

Key Executives

Chairperson

Ownership Details

Pharmaceuticals Holding Company
60%

Key Stats

Select Items to chart them. 2017 Q1
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 543,535
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.

Financials

Competitors - Egypt

EGP | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest